Centenara Labs
PrivateLast Round
Series B
Sep 11, 2023
Total Funding Raised
$75M
Company Overview
Centenara Labs is a biotechnology company specializing in the development of advanced drug therapies aimed at curing age-related diseases and enhancing human longevity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centenara Labs Comps
Public and private peers based on sector, stage, and business model.
Centenara Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 11, 2023 |
Centenara Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series B |
| Apeiron Investment Group | Series B |
| Mubadala Capital | Series B |
Centenara Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centenara Labs's valuation, stock price, and market status.
